시장보고서

상품코드

1741307

진토제 시장 : 약제 클래스별, 투여 경로별, 유통 채널별, 지역별

Nausea Medicine Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

발행일: 2025년 03월 | 리서치사:

Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

진토제 시장은 2025년에는 31억 7,000만 달러, 2032년에는 48억 6,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 연평균 성장률(CAGR)은 6.3%를 나타낼 전망입니다.

보고 범위		보고서 세부정보
기준 연도	2024년	2025년 시장 규모	31억 7,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간: 2025-2032년 CAGR :	6.30%	2032년 가치 예측	48억 6,000만 달러

메스꺼움은 종종 구토 충동을 동반하는 불온한 감각이며, 일상 생활에 큰 지장을 초래합니다. 현대 의료의 중요한 측면인 메스꺼움 의학은 고통스러운 증상을 완화하고 전반적인 웰빙을 개선하는 것을 목표로 합니다. 액제, 패치 등 다양한 형태가 있습니다. 진토제는 수용체를 효과적으로 차단함으로써 멀미, 화학 요법으로 인한 메스꺼움, 임신 관련 불편함 및 기타 관련 질환으로 고통받는 환자에게 필요한 완화를 제공합니다.

시장 역학 :

메스꺼움의 유병률 증가, 약물 제형의 진보, 노인 인구 증가, 연구 개발 활동의 활성화가 예측 기간 중 세계의 진토제 시장의 성장을 가속할 것으로 예측됩니다. Vanda Pharmaceuticals Inc.는 멀미 치료제에 대한 3상 임상시험 결과를 발표하여, 멀미 구토 예방에 도움이 된다는 이전에 발표된 연구 결과를 확인했습니다.

그러나 부작용과 안전성에 대한 우려, 진토제의 고비용, 특정 원인을 겨냥한 치료법의 부족, 일부 사례의 제한적인 효율성 등이 예측 기간에 있어서 세계의 진토제 시장의 성장을 방해할 것으로 예측됩니다.

본 조사의 주요 특징

본 보고서는 진토제 세계 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모 및 복합연간 성장률(CAGR%)을 제공합니다.
또, 다양한 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 설명하고 있습니다.
또 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등의 파라미터에 근거해, 진토제 세계 시장에 있어서의 주요 기업 프로파일을 제공합니다.
이 보고서의 통찰은 마케팅 담당자와 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 할 수있게합니다.
진토제 세계 시장 보고서는 투자자, 공급업체, 제품 제조 업체, 유통 업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자에 대응하고 있습니다.
이해관계자는 세계의 진토제 시장의 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 3.17 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.30%	2032 Value Projection:	USD 4.86 Bn

Nausea is an unsettling sensation that is often accompanied by the urge to vomit, which can significantly disrupt a daily life. Nausea medicine which is a vital aspect of modern healthcare, aims to alleviate the distressing symptom and improve overall well-being. The medicine that is designed to target body's specific receptors is responsible for nausea and vomiting. These medications come in various forms, including pills, liquids and patches. By effectively blocking the receptors, nausea medicine provides the needed relief to patients who are suffering from motion sickness, chemotherapy-included nausea, pregnancy-related discomfort, and other related conditions. This introduction delves into the importance of these medicines in enhancing quality of life for individuals plagued by nauseous episodes.

Market Dynamics:

Increasing prevalence of nausea, advancements in drug formulations and increasing geriatric population, increasing research and development activities is anticipated to drive growth of the global nausea medicine market over the forecast period. Moreover, growing awareness and diagnosis is also expected to boost the growth of the global nausea medicine market over the forecast period. Development of targeted therapies, expansion into emerging markets, combination therapies and non-pharmacological interventions are expected to create growth opportunities for the global nausea medicine market during the forecast period.For instance, in May 2023, Vanda Pharmaceuticals Inc., a worldwide biopharmaceutical company, revealed the results of its Phase III research of tradipitant in motion sickness, thereby confirming the previously published findings that tradipitant is beneficial in the prevention of motion sickness vomiting. The Phase III study was carried out on boats in U.S. coastal waters under real-world situations.

However, adverse effects and safety concerns, high cost of nausea medicines, lack of targeted therapies for specific causes and limited efficiency in some cases are expected to hamper growth of the global nausea medicine market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global nausea medicine market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global nausea medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, Pfizer Inc., Novartis International AG, Sanofi S.A., Merck & Co., Inc., Johnson & Johnson, Bayer AG, Takeda Pharmaceutical Company Limited, AstraZeneca plc, Eli Lilly and Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global nausea medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analysing the global nausea medicine market

Detailed Segmentation:

Global Nausea Medicine Market, By Drug Class:
- Antihistamines
- Anticholinergics
- Serotonin Antagonists
- Dopamine Antagonists
- Cannabinoids
- Others
Global Nausea Medicine Market, By Route of Administration:
- Oral
- Injectable
- Transdermal
- Rectal
- Others
Global Nausea Medicine Market, By Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Others
Global Nausea Medicine Market, By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- GlaxoSmithKline plc.
- Pfizer Inc.
- Novartis International AG
- Sanofi S.A.
- Merck & Co., Inc.
- Johnson & Johnson
- Bayer AG
- Takeda Pharmaceutical Company Limited
- AstraZeneca plc
- Eli Lilly and Company

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing prevalence of nausea
- Restraints
Adverse effects and safety concerns
- Opportunities
Development of targeted therapies
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations

4. Global Nausea Medicine Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Nausea Medicine Market, By Drug Class, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Antihistamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Anticholinergics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Serotonin Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Dopamine Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cannabinoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Other
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Nausea Medicine Market, By Route of Administration, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Rectal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Nausea Medicine Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Nausea Medicine Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - China
  - Japan
  - India
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 -2032, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profile
- GlaxoSmithKline plc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Novartis International AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Sanofi S.A.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Merck &Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Johnson & Johnson
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Takeda Pharmaceutical Company Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- AstraZeneca plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Eli Lily and Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies

10. Section

References
Research Methodology
About us and Services

진토제 시장 : 약제 클래스별, 투여 경로별, 유통 채널별, 지역별

Nausea Medicine Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

시장 역학 :

본 조사의 주요 특징

목차

제1장 조사의 목적과 전제조건

제2장 시장 전망

제3장 시장 역학, 규제, 동향 분석

제4장 세계의 진토제 시장, 코로나바이러스(COVID-19) 팬데믹의 영향

제5장 세계의 진토제 시장, 약제 클래스별, 2020년-2032년

제6장 세계의 진토제 시장, 투여 경로별, 2020년-2032년

제7장 세계의 진토제 시장, 유통 채널별, 2020년-2032년

제8장 세계의 진토제 시장, 지역별, 2020년-2032년

제9장 경쟁 구도

제10장 섹션